Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 9:11:89.
doi: 10.1186/1471-2334-11-89.

Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test

Affiliations

Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test

Mengistu Legesse et al. BMC Infect Dis. .

Abstract

Background: There is little information concerning community-based prevalence of latent tuberculosis infection (LTBI) using T-cell based interferon-γ (IFN-γ) release assays (IGRAs), particularly in TB endemic settings. In this study, the prevalence of LTBI in the Afar pastoral community was assessed using QuantiFERON-TB Gold In-Tube (QFTGIT) and tuberculin skin tests (TST).

Methods: A community-based cross-sectional survey of LTBI involving 652 apparently healthy adult pastoralists was undertaken in the pastoral community of Amibara District of the Afar Region between April and June 2010.

Results: The prevalence of LTBI was estimated as 63.7% (363/570) using QFTGIT at the cut-off point recommended by the manufacturer (≥0.35 IU/ml IFN-γ), while it was 74.9% (427/570) using a cut-off point≥0.1 IU/ml IFN-γ. The QFTGIT-based prevalence of LTBI was not significantly associated with the gender or age of the study participants. However, the prevalence of LTBI was 31.2% (183/587) using TST at a cut-off point≥10 mm of skin indurations, and it was higher in males than females (36.8% vs. 23.5%, X2=11.76; p<0.001). There was poor agreement between the results of the tests (k=0.098, 95% CI, 0.08-0.13). However, there was a positive trend between QFTGIT and TST positivity (X2=96.76, P<0.001). Furthermore, individuals with skin indurations≥10 mm were 13.6 times more likely to have positive results using QFTGIT than individuals with skin indurations of 0 mm (adjusted OR=13.6; 95%CI, 7.5 to 24.7, p<0.001).

Conclusions: There is currently no agreed gold standard for diagnosis of LTBI. However, the higher prevalence of LTBI detected using QFTGIT rather than TST suggests that QFTGIT could be used for epidemiological studies concerning LTBI at the community level, even in a population unreactive to TST. Further studies of adults and children will be required to assess the effects of factors such as malnutrition, non-tuberculosis mycobacterial infections, HIV and parasitic infections on the performance of QFTGIT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The trend of proportion of positivity by QFTGIT against the skin test indurations. Whole blood samples were collected from study participants directly into tubes containing TB-specific antigens, mitogen and nil. The samples were incubated for 24 hours at 37°C, plasma was collected and IFNγ assay was performed using ELISA. The results were interpreted as positive, negative or indeterminate on the basis of the manufacturer's recommended cut-off value (IFN-γ ≥ 0.35 IU/ml) using QFTGIT analysis software developed by the company. Tuberculin skin test (TST) was also performed by administrating 0.1 ml (2T.U/0.1 ml) tuberculin PPD RT23 (Statens Serum Institute, Copenhagen, Denmark) intradermally in the middle of the left forearm. The diameter of the indurations was measured transversely after 48-72 h using a ball-point pen and flexible plastic ruler. The subjects were categorized in to three groups based on the size of skin test induration (0 mm, >0 < 10 mm and ≥ 10 mm) and the positivity by QFTGIT was compared for the three groups.

Similar articles

Cited by

References

    1. WHO. Global Tuberculosis Control, Epidemiology, Strategy. Geneva, Switzerland: WHO report; 2009.
    1. WHO. The world health report 1999. Geneva: WHO; 1999. p. 110.
    1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. WHO Golbal Surveillance and Monitoring Project. JAMA. 1999;287:677–686. doi: 10.1001/jama.282.7.677. - DOI - PubMed
    1. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10:1192–1204. - PubMed
    1. von Reyn CF, Horsburgh CR, Olivier KN, Barnes PF, Waddell R, Warren C, Tvaroha S, Jaeger AS, Lein AD, Alexander LN, Weber DJ, Tosteson AN. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis. 2001;5:1122–1128. - PubMed

Publication types

Substances

LinkOut - more resources